ChinaBio® Partnering Forum 2016 returning to Suzhou, China's life science hub, May 18-19, 2016
SUZHOU, China, March 14, 2016 /PRNewswire/ — The 8(th) annual ChinaBio [http://www.ebdgroup.com/cbpf/index.php]® [http://www.ebdgroup.com/cbpf/index.php]Partnering Forum 2016 [http://bit.ly/22g4VMm] life science partnering event will return to Suzhou, China, May 18-19. Suzhou is an active biopharma hub and the home of international and China pharmaceutical and medical companies, specializing in drug discovery, diagnostics, and medical devices. China is now the world’s second largest and fastest growing major pharma market and the event will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies to capitalize on this high-growth potential.
“China is transforming into an innovation-based economy,” said Greg B. Scott, Founder of ChinaBio® Group. “Suzhou BioBay has aggressively fostered innovation in medical devices, pharmaceuticals, and diagnostics, as well as research-related services. Many of the companies as well as companies from all over China are eager to partner with western companies.”
Hengrui, a leading developer of novel cancer therapeutics in China, is a regular attendee and presenter at ChinaBio® Partnering Forum. “At ChinaBio®, we meet many companies from here in China as well as from the US and Europe, and we can discuss possible collaborations to help bring new medicines to the market,” said Lianshan Zhang, PhD, President of Global R&D at Hengrui.
Innovative companies, organizations and researchers interested in partnering their technologies or products, initiating strategic alliances, or tapping into the financing network in China may apply to present [http://bit.ly/1RhphDa] at the event.
partneringONE® is EBD Group’s sophisticated, web-based partnering system that enables event delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
Attendees may register [http://bit.ly/1QSRXjL] before March 18, 2016 to save USD 200 off the regular registration fee.
About ChinaBio® Group:
Since its founding in 2007, ChinaBio® Group has successfully helped nearly 100 US, European and Asia-Pacific life science companies achieve success in China. Leveraging their consulting and advisory teams’ significant experience in China’s life science industry, ChinaBio has helped its clients identify over 1,000 in-/out-licensing and M&A opportunities and raise over $500M in funding in China. ChinaBio’s clients have included many global pharma and life science companies as well as early stage and mid-size companies in Europe and the US. ChinaBio has also organized over 30 conferences in China focused on investment and partnering, and publishes ChinaBio® Today, the most widely read source for China life science news. ChinaBio® Group is headquartered in Shanghai with staff in San Diego, Silicon Valley, Canada and Switzerland. More information is available at www.chinabio.com [http://www.chinabio.com/]
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
— BIO-Europe [http://bit.ly/1Wl6yVs]® and BIO-Europe Spring
[http://bit.ly/1QYh2X6]®, Europe’s largest life science partnering
conferences, supported by the Biotechnology Industry Organization (BIO)
— BioPharm America [http://bit.ly/1U1slEg](TM), the fastest growing
partnering event in North America
— Biotech Showcase [http://bit.ly/1SNddZx](TM), a unique forum in San
Francisco for presenting to investors and business development
executives, co-produced with Demy-Colton Life Science Advisors
— BioEquity Europe [http://bit.ly/1TIUFef], the investor conference
co-organized with BioCentury Publications and BIO
— ChinaBio® Partnering Forum [http://bit.ly/1LmBog4], the first dedicated
biotech/pharma partnering conference in China, co-produced with
— Biolatam [http://bit.ly/1QYhg0w]®, facilitating partnering among global
life sciences executives in Latin America’s vibrant life science hubs
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com [http://www.ebdgroup.com/].
CONTACT: Erin Righetti, EBD Group, +1 760 930 0500,email@example.com, or Jean Meng, ChinaBio® Group, 780 Cailun Road,#822, Shanghai 201203 China, From China: +86 21 5137 0751, From USA: +1 858859 1860, Jean.Meng@chinabio.com
Web site: http://www.ebdgroup.com/